tiprankstipranks
Trending News
More News >
CytoMed Therapeutics Limited (GDTC)
NASDAQ:GDTC
US Market

CytoMed Therapeutics Limited (GDTC) Income Statement

Compare
17 Followers

CytoMed Therapeutics Limited Income Statement

Last quarter (Q2 2025), CytoMed Therapeutics Limited's total revenue was $105.70K, an increase of 27.87% from the same quarter last year. In Q2, CytoMed Therapeutics Limited's net income was $-882.30K. See CytoMed Therapeutics Limited’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 24Dec 23Dec 22Dec 21Dec 20
Total Revenue
$ 52.01K$ 290.56K$ 0.00$ 84.18K$ 44.92K
Gross Profit
$ 52.38K$ 381.92K$ -81.03K$ 81.59K$ 41.43K
Operating Expenses
$ 1.87M$ 1.58M$ 1.62M$ 937.15K$ 891.67K
Depreciation and Amortization
$ 91.59K$ 77.47K$ 293.32K$ 243.92K$ 220.99K
EBITDA
$ -1.79M$ -2.94M$ -1.10M$ -1.05M$ -776.21K
Operating Income
$ -2.63M$ -3.20M$ -1.70M$ -1.40M$ -1.00M
Other Income/Expenses
$ 739.13K$ 122.21K$ -572.86K$ -128.34K$ -400.12K
Pretax Income
$ -1.89M$ -3.08M$ -2.27M$ -1.53M$ -1.40M
Net Income
$ -1.88M$ -3.13M$ -2.27M$ -1.53M$ -1.47M
Per Share Metrics
Basic EPS
$ -0.16$ -0.29$ -0.30$ -0.22$ -0.25
Diluted EPS
$ -0.16$ -0.29$ -0.30$ -0.22$ -0.25
Weighted Average Shares Outstanding
11.54M 10.63M 7.92M 6.93M 5.90M
Weighted Average Shares Outstanding (Diluted)
11.54M 10.63M 7.92M 6.93M 5.90M
Currency in USD

CytoMed Therapeutics Limited Earnings and Revenue History